The DOI matches its Crossref record; the references it cites are not checked yet.
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
Abstract
Cerebral X-linked adrenoleukodystrophy (X-ALD) is a disorder of very-long-chain fatty acid metabolism, adrenal insufficiency, and cerebral demyelination. Death occurs within 2 to 5 years of clinical onset without hematopoietic cell transplantation (HCT). One hundred twenty-six boys with X-ALD received HCT from 1982 to 1999. Survival, engraftment, and acute graft-versus-host disease were studied. Degree of disability associated with neurologic and neuropsychological function and cerebral demyelination were evaluated before and after HCT. Complete data were available and analyzed for 94 boys with cerebral X-ALD. The estimated 5- and 8-year survival was 56%. The leading cause of death was disease progression. Donor-derived engraftment occurred in 86% of patients. Demyelination involved parietal-occipital lobes in 90%, leading to visual and auditory processing deficits in many boys. Overall 5-year survival of 92% in patients with 0 or 1 neurologic deficits and magnetic resonance imaging (MRI) severity score less than 9 before HCT was superior to survival for all others (45%; P < .01). Baseline neurologic and neuropsychological function, degree of disability, and neuroradiologic status predicted outcomes following HCT. In this first comprehensive report of the international HCT experience for X-ALD, we conclude that boys with early-stage disease benefit from HCT, whereas boys with advanced disease may be candidates for experimental therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early-stage treatment of childhood cerebral ALD with hematopoietic stem cell transplantation and, more recently, gene therapy can arrest disease progression if performed in the window of opportunity when the MRI is abnormal but neurological symptoms are not yet apparent [7,38,43,44,45,46,47,48,49,50].”
From Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy (2022) · cites this paper as [43]
In the citing paper
“In cases where brain inflammation is detected early, it can be arrested by hematopoietic stem cell transplantation (HSCT).8”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [8]
In the citing paper
“For instance, HSCT is only effective in CALD when performed at an early disease stage, because cerebral inflammation still progresses for 12–18 months after the procedure.8,66”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [8]
In the citing paper
“Allogeneic hematopoietic stem-cell transplantation (HSCT) is the standard of care for cerebral adrenoleukodystrophy and can stabilize the disease and preserve function if it is performed at an early stage when demyelination is limited.”
From Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy (2024) · cites this paper as [8]
In the citing paper
“Allogeneic transplantation is the only effective therapy for cerebral adrenoleukodystrophy that has been identified to date, and it is more likely to be effective if it is performed at an early stage of neurodegeneration.5–8”
From Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy (2017) · cites this paper as [5]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 31 · Cited by 374
Research works printed but not linked: 6
- Aubourg P, Chaussain J, Dulac O, Arthuis M. Adrenoleukodystrophy in childhood: a review of 20 cases. Arch Fr Pediatr.1982;39: 663-669.
- Moser H, Naidu S, Kumar A, Rosenbaum A. The adrenoleukodystrophies. Crit Rev Neurobiol.1987;3: 29-88.
- Krivit W, Shapiro EG, Lockman LA, et al. Recommendation for treatment of childhood cerebral form of adrenoleukodystrophy. In: Hobbs J, Riches P, eds. Correction of Certain Genetic Diseases by Transplantation 1991. London, United Kingdom: The COGENT Trust; 1992: 38-49.
- Shapiro E, Lockman L, Balthazor M, et al. Neuropsychological and neurological function and quality-of-life before and after bone marrow transplantation for adrenoleukodystrophy. In: Ringden O, Hobbs J, Steward C, eds. Correction of Genetic Diseases by Transplantation 1997. London, United Kingdom: The COGENT Press; 1997: 52-62.
- Malm G, Ringdén O, Dobeln U, et al. Treatment of adrenoleukodystrophy with bone marrow transplant. In: Ringden O, Hobbs J, Steward C, eds. Correction of Genetic Diseases by Transplantation 1997. London, United Kingdom: The CO-GENT Press; 1997: 49-51.
- Snedecor G, Cochran W. Statistical Methods. 8th ed. Ames, Iowa: Iowa State University Press; 1989.
Metadata
- Authors
- Peters, C., Charnas, L. R., Tan, Y., Ziegler, R. S., Shapiro, E. G., DeFor, T., Grewal, S. S., Orchard, P. J., Abel, S. L., Goldman, A. I., Ramsay, N. K. C., Dusenbery, K. E., Loes, D. J., Lockman, L. A., Kato, S., Aubourg, P. R., Moser, H. W., & Krivit, W.
- Affiliations
- Kennedy Krieger Institute (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-08-01
- Volume
- 104
- Issue
- 3
- Pages
- 881-888
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2168472266
- Cited by
- 374
- References
- 31
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 15 · 2023: 12 · 2022: 18 · 2021: 24 · 2020: 14 · 2019: 17 · 2018: 18 · 2017: 17 · 2016: 11 · 2015: 13 · 2014: 23 · 2013: 18 · 2012: 13
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns029099-05)
- National Institute of Neurological Disorders and Stroke (NS 29099)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- hematopoietic stem cell transplantation, very long chain fatty acids, brain demyelination, survival, engraftment, graft-versus-host disease, neurodisability, neuropsychological performance, disease progression, treatment outcome prediction
- MeSH terms
- Adrenoleukodystrophy, Cause of Death, Graft vs Host Disease, Humans, Immunosuppressive Agents, Retrospective Studies, Time Factors, Whole-Body Irradiation, Survival Analysis, Treatment Outcome, Disease Progression, Transplantation Conditioning, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. https://app.cochat.ai/papers/10.1182/blood-2003-10-3402
- The paper
- Peters, C., Charnas, L. R., Tan, Y., Ziegler, R. S., Shapiro, E. G., DeFor, T., Grewal, S. S., Orchard, P. J., Abel, S. L., Goldman, A. I., Ramsay, N. K. C., Dusenbery, K. E., Loes, D. J., Lockman, L. A., Kato, S., Aubourg, P. R., Moser, H. W., & Krivit, W. (2004). Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. https://doi.org/10.1182/blood-2003-10-3402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.